| Variable |
DI (diabetes and ischemia)
N=152 |
DO (diabetes only)
N=173 |
IO (ischemic only group)
N=449 |
ND (nor diabetic nor ischemia)
N=836 |
P |
| Chronic total occlusion |
43.4 |
22.0 |
37.0 |
21.6 |
<0.001 |
| In stent-restenosis |
12.6 |
4.1 |
16.7 |
3.5 |
<0.001 |
| Coronary perforation |
0.7 |
0.6 |
0.5 |
0.5 |
0.987 |
| Unprotected left main coronary artery |
8.1 |
6.4 |
12.0 |
8.5 |
0.097 |
| Bifurcation |
23.4 |
18.9 |
17.5 |
16.4 |
0.215 |
| Saphenous vein graft PCI |
13.5 |
0 |
4.7 |
0.7 |
<0.001 |
| Thrombosis |
3.6 |
11.3 |
4.8 |
14.2 |
<0.001 |
| Vessels <2.75 mm |
38.0 |
29.1 |
25.8 |
23.7 |
0.003 |
| American College of Cardiology/American Heart Association type C lesion |
26.4 |
21.5 |
25.5 |
14.6 |
<0.001 |
| Total number of diseased vessels |
2.36±0.73 |
2.07±0.78 |
2.24±0.770 |
1.94±0,813 |
0.029 |
| Total number of treated vessels |
1.68±0.83 |
1.69±0.75 |
1.73±0.737 |
1.63±0.727 |
0.318 |
| Total number of target lesions |
2.54±1.48 |
2.42±1.44 |
2.39±1.27 |
2.26±1.32 |
0.006 |
| Total number of stent |
2.73±1.71 |
2.54±1.62 |
2.31±1,34 |
2.30±1,49 |
<0.0001 |
| Total length of stent (mm) |
42.70±29.18 |
35.95±24.8 |
33.90±22.41 |
32.61±21.70 |
<0.0001 |
| Total BMS number |
1.77±2.33 |
1.78±1.44 |
1.59±1.39 |
1.64±2.082 |
0.018 |
| Total BMS length (mm) |
36.10±24.75 |
29.38±17.98 |
29.03±20.75 |
29.29±21.44 |
0.082 |
| Total DES number |
0.66±1.92 |
0.76±1.23 |
0.72±1.12 |
0.66±1.78 |
0.035 |
| Total DES length (mm) |
35.89±29.2 |
30.46±21.18 |
29.46±19.44 |
30.26±20.34 |
0.730 |
| Intra-aortic balloon pump |
1.3 |
1.8 |
2.1 |
1.2 |
0.714 |
| Intravenous glycoprotein IIb/IIIa inhibitors |
18.2 |
34.1 |
13.5 |
25.3 |
<0.001 |
BMS=bare-metal stent; DES=drug-eluting stent